Clinical trial
Trial Evaluating Safety, Tolerability and Immune Response of AG-707
NCT00231049 · Agenus Inc., Industry · Completed
Key facts
| NCT number | NCT00231049 |
|---|---|
| Title | Trial Evaluating Safety, Tolerability and Immune Response of AG-707 |
| Official title | A Phase 1 Trial Evaluating Safety, Tolerability and Immune Response of AG-707 Compared to Placebo in HSV-2 Seropositive Patients |
| Lead sponsor | Agenus Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Genital Herpes |
| Intervention type | Drug |
| Interventions | AG-707 |
| Enrollment | 35 |
| Start date | Mar 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Oct 27, 2008 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: